Generalized tonic-clonic seizures, the type most people picture when they hear the word “seizure,” are treated with a combination of daily preventive medications, emergency rescue drugs, and in some cases surgical or device-based interventions. The core goal is straightforward: stop seizures from happening and, when they do happen, end them quickly. About 70% of people with epilepsy can become seizure-free with the right medication, but getting there often involves trial, adjustment, and close follow-up.
First-Line Medications
The drugs most commonly prescribed to prevent generalized tonic-clonic seizures are what neurologists call “broad-spectrum” anti-seizure medications. These include valproate, lamotrigine, levetiracetam, and topiramate. Each can be effective, but they are not interchangeable, and choosing among them depends on the person’s age, sex, other health conditions, and how they tolerate side effects.
A network analysis comparing several of these drugs found that lamotrigine had the highest probability of making patients seizure-free, followed by levetiracetam, topiramate, and valproate, while phenytoin performed worse than valproate at achieving seizure freedom.1PubMed. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses These rankings reflect probabilities across study populations, not guarantees for any individual. In practice, valproate remains widely used, particularly for men and women who are not of childbearing age, because it has decades of clinical experience behind it and works well across multiple seizure types. Lamotrigine and levetiracetam have become increasingly popular as first choices, partly because their side-effect profiles are more favorable for many people.
One important caveat: sodium-channel-blocking drugs like carbamazepine and phenytoin, which are effective against focal seizures, can sometimes worsen generalized seizure types like absences or myoclonic jerks. For that reason, unless a doctor has confirmed the seizures start from a focal point in the brain, treatment usually begins with one of the broad-spectrum options rather than a narrow-spectrum drug.2PubMed Central. The adolescent or adult with generalized tonic-clonic seizures
How Anti-Seizure Drugs Work
These medications calm down overactive brain signaling through a few different routes. Some, like phenytoin and carbamazepine, block the ability of neurons to fire over and over in rapid bursts by interfering with sodium channels. Others, like phenobarbital and benzodiazepines, boost the brain’s main inhibitory chemical messenger, GABA, making it harder for a seizure to gain momentum. Valproate works through multiple pathways at once, which is part of why it covers several seizure types.3PubMed. Mechanisms of anticonvulsant drug action. I. Drugs primarily used for generalized tonic-clonic and partial epilepsies Newer drugs have their own mechanisms: levetiracetam, for instance, works on a protein involved in the release of chemical signals between neurons, while perampanel blocks a specific type of excitatory receptor. The practical takeaway is that when one drug fails, switching to one with a different mechanism often succeeds.
When a Seizure Becomes an Emergency
Most generalized tonic-clonic seizures end on their own within one to three minutes. When a seizure lasts longer than five minutes, or when seizures cluster without the person recovering in between, the situation is classified as status epilepticus, a medical emergency that requires immediate drug treatment.
The first step in the emergency department is almost always a fast-acting benzodiazepine, typically intravenous lorazepam or intramuscular midazolam. If the seizure does not stop, doctors move to a “second-line” intravenous agent. A large randomized trial compared three options for this stage: levetiracetam, fosphenytoin (a form of phenytoin), and valproate. All three performed similarly. Seizure cessation and improved consciousness at 60 minutes occurred in roughly 45-47% of patients across all three arms, with no clear winner.4PubMed Central. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus An earlier observational study, however, found that valproate had a lower failure rate than levetiracetam when used as second-line treatment for status epilepticus, with levetiracetam failing more than twice as often.5PubMed. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam In practice, hospital protocols vary, and the choice often depends on what the patient is already taking and what side effects the clinical team wants to avoid.
Rescue Medications Outside the Hospital
Not every prolonged seizure or seizure cluster happens near a hospital. For people with a known pattern of breakthrough seizures, doctors prescribe “rescue” medications that a caregiver or even the person themselves can administer at home, at school, or in public. These are typically benzodiazepines delivered through non-intravenous routes: nasal sprays, buccal gels applied inside the cheek, or rectal gels.
Intranasal midazolam, for example, has been shown to delay seizure recurrence and reduce the odds of a seizure progressing to a full tonic-clonic event.6PubMed. Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic-clonic seizures Diazepam nasal spray is another option that has gained traction because of its ease of use: in a study of patients and caregivers, over 90% of caregivers rated administration as extremely or very easy, and about 40% of patients were able to self-administer the spray, most of whom also found it simple.7Epilepsy & Behavior. Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters Caregivers consistently rank ease of administration as the most important feature of a rescue medication, ahead even of raw effectiveness, because a drug that is hard to give under stress often does not get given at all.8PubMed. Caregiver preferences and training needs in the administration of rescue medication for prolonged convulsive seizures in children and adolescents with epilepsy
Newer and Add-On Therapies
When first-line drugs do not fully control seizures, doctors add a second (or sometimes third) medication. Perampanel is one of the more notable newer options. A phase III trial in patients with generalized tonic-clonic seizures showed that perampanel reduced seizure frequency with a tolerable side-effect profile and did not worsen other seizure types like absences or myoclonic jerks.9PubMed. Perampanel for the treatment of primary generalized tonic-clonic seizures in idiopathic generalized epilepsy Lacosamide and zonisamide are also being explored as add-on treatments, though evidence for their use in generalized epilepsy is still building.10PubMed. Anticonvulsant drugs for generalized tonic-clonic epilepsy
Cannabidiol (CBD) has received a lot of public attention. It is FDA-approved for certain severe childhood epilepsy syndromes, and animal research has shown that CBD can reduce the severity and duration of tonic-clonic seizures in a dose-dependent way.11PubMed Central. Cannabidiol attenuates generalized tonic-clonic seizures and suppresses limbic seizures in the Genetically Epilepsy Prone Rats (GEPR-3) strain Clinical reports in children with treatment-resistant epilepsy have also documented good responses, with drop attacks including tonic-clonic seizures responding well to CBD.12PubMed. Cannabidiol in children with treatment-resistant epilepsy with myoclonic-atonic seizures It is worth noting that prescription CBD (Epidiolex) is a different product from the CBD supplements sold in health stores; the prescription version is pharmaceutical-grade, dosed precisely, and studied in controlled trials.
The Ketogenic Diet
Dietary therapy sounds like an alternative medicine footnote, but the ketogenic diet has been used for drug-resistant epilepsy since the 1920s and has real evidence behind it. The diet, which is very high in fat and very low in carbohydrates, forces the body to burn fat for fuel instead of glucose, producing molecules called ketones. How exactly this reduces seizures is still debated, but the clinical results are well-documented. Tonic-clonic seizures are among the seizure types that respond particularly well to ketogenic dietary therapy.13ScienceDirect. Ketogenic diet in clinical practices The diet is demanding to maintain, requiring careful meal planning and regular blood and urine monitoring, so it is most commonly used in children with severe epilepsy who have not responded to multiple medications. Modified versions, like the modified Atkins diet, offer somewhat easier protocols with similar principles.
Surgery and Brain Stimulation Devices
For people whose seizures resist medications, two broad categories of intervention exist beyond drugs and diet: surgical procedures and implanted stimulation devices.
Corpus Callosotomy
This surgery severs part or all of the corpus callosum, the thick bundle of nerve fibers connecting the brain’s two hemispheres. The idea is to prevent seizure activity from spreading rapidly across the entire brain. It does not cure epilepsy but can dramatically reduce the frequency and severity of generalized seizures, especially those that cause falls. In one series of pediatric patients, about 80% of those with tonic-clonic seizures had at least a 50% decrease in seizure frequency, and 60% had at least an 80% reduction.14PubMed. Refractory generalized seizures: response to corpus callosotomy and vagal nerve stimulation Another pediatric series found that 65% of patients with generalized seizures leading to falls achieved at least 50% seizure reduction, and 35% became entirely seizure-free.15PubMed Central. Corpus Callosotomy for Intractable Epilepsy Revisited: The Children’s Hospital of Michigan Series Callosotomy is considered palliative rather than curative, but for someone who falls and injures themselves with every seizure, even a partial reduction can be life-changing.
Vagus Nerve Stimulation and Deep Brain Stimulation
Vagus nerve stimulation (VNS) involves a small device implanted in the chest that sends regular electrical pulses to the vagus nerve in the neck, which relays signals to the brain. It has been used for decades, and tonic-clonic seizures show some of the best response rates among generalized seizure types.16PubMed. Vagus nerve stimulation in patients with therapy-resistant generalized epilepsy Deep brain stimulation (DBS), which places electrodes directly in brain structures like the thalamus, is a newer approach. A meta-analysis comparing the two found that VNS reduced seizures by about 48% on average, while DBS achieved a roughly 65% reduction in patients with generalized epilepsy.17PubMed. Neurostimulation in generalized epilepsy: A systematic review and meta-analysis DBS requires a more complex surgical procedure and is not as widely available, but the difference in efficacy has generated considerable interest.
Side Effects and Their Impact on Daily Life
Seizure control is only half the equation. The medications that prevent seizures can introduce their own problems, and for many people, side effects are what ultimately drives a switch from one drug to another. The most common complaints across anti-seizure medications are drowsiness, dizziness, and weight changes, but the details vary considerably by drug.
Cognitive effects deserve special attention because they directly affect work, school, and quality of life. Older drugs like phenobarbital tend to dull thinking more than newer alternatives. Among the newer drugs, topiramate stands out as the one most consistently linked to cognitive trouble, including word-finding difficulty and slowed processing speed.18PubMed Central. Cognitive effects of antiepileptic drugs Zonisamide carries a similar, though generally milder, risk. On the other hand, lamotrigine and levetiracetam tend to leave cognition relatively intact, and cannabidiol may even have modest positive effects on some cognitive measures.19PubMed Central. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies
Behavioral side effects are another consideration. Levetiracetam, despite being well-tolerated cognitively, is known for causing irritability and sometimes aggression in a subset of patients. Perampanel and brivaracetam can do the same. Valproate, lamotrigine, and rufinamide tend to be more behaviorally neutral.20PubMed. Cognitive and behavioral impact of antiseizure medications, neuromodulation, ketogenic diet, and surgery in Lennox-Gastaut syndrome: A comprehensive review When someone experiences mood changes or personality shifts on a new medication, it is worth bringing up with their neurologist rather than assuming it is unrelated.
Pregnancy and Anti-Seizure Medications
Treatment decisions become considerably more complex for women who are pregnant or planning to become pregnant. Uncontrolled tonic-clonic seizures during pregnancy carry serious risks for both mother and baby, so stopping medication is rarely an option. At the same time, some drugs carry their own risks to fetal development.
Valproate poses the greatest concern. It has been consistently linked to higher rates of birth defects and to neurodevelopmental effects in children exposed during pregnancy, including increased likelihood of autism, intellectual disability, and ADHD.21Nature Communications. Antiseizure medication use during pregnancy and children’s neurodevelopmental outcomes Topiramate and phenobarbital also carry elevated risks, though lower than valproate’s. Lamotrigine and levetiracetam, by contrast, are considered relatively safe during pregnancy and have become the preferred options for women of childbearing age.22BMJ. Management of epilepsy during pregnancy and lactation Carbamazepine falls somewhere in between, with a modest increase in risk for some neurodevelopmental outcomes. The use of higher-risk drugs during pregnancy has declined over the past decade as awareness of these findings has grown.23PubMed Central. Management of Anti-Seizure Medications during Pregnancy: Advancements in The Past Decade
Pregnancy also changes how the body processes many drugs, often lowering blood levels and increasing the risk of breakthrough seizures. This is one of the situations where drug-level monitoring becomes especially important.
Monitoring Drug Levels
Anti-seizure medications have a therapeutic window: too little and seizures break through, too much and side effects become intolerable. For drugs like phenytoin, which have unpredictable dose-to-blood-level relationships, regular blood tests to measure the drug concentration are standard. But monitoring is useful for nearly all anti-seizure drugs in certain situations: when someone first achieves seizure control (to record a personal “target” level), when seizures return unexpectedly, when side effects appear, when a potentially interacting medication is added, or during pregnancy.24PubMed. Antiepileptic drugs–best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies The goal is personalized dose adjustments rather than chasing a one-size-fits-all “normal range.”25Therapeutic Drug Monitoring. Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update
Why Adherence Matters So Much
Perhaps the single most underappreciated factor in seizure treatment is whether people actually take their medication consistently. Missing doses is remarkably common, and the consequences are real: patients who do not take their medications as prescribed have significantly worse seizure control. In one study, the rate of poorly controlled seizures was about 78% in non-adherent patients compared to 49% in adherent patients.26PubMed Central. Prevalence of Non-adherence to Antiepileptic Drugs in Patients With Epilepsy Presenting to Emergency With Fits
The most common reason people miss doses is simply forgetting. Phone alarms, pill organizers, and digital reminders help, but so does simplifying the regimen itself. Taking fewer pills, fewer times per day, makes it easier to stay consistent.27Journal of Neurosciences in Rural Practice. Nonadherence to Antiepileptic Medications: Still a Major Issue to be Addressed in the Management of Epilepsy Stigma around epilepsy, cost of medications, and side effects also drive non-adherence. Education about what happens when doses are skipped, not in a scare-tactic way but as honest information, has been shown to improve adherence rates.28PubMed Central. Antiepileptic Drug Nonadherence and Its Predictors among People with Epilepsy
Reducing the Risk of Sudden Unexpected Death in Epilepsy
SUDEP, sudden unexpected death in epilepsy, is the most feared complication of uncontrolled seizures. It is uncommon overall, but the single strongest risk factor is ongoing generalized tonic-clonic seizures. Freedom from tonic-clonic seizures is strongly linked to a lower risk of SUDEP, which gives the effort to control these seizures an urgency beyond just quality of life.29PubMed Central. Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors A nationwide study reinforced that medication adherence and aggressive treatment of poorly controlled tonic-clonic seizures are critical steps in reducing SUDEP risk, and also suggested an intriguing, though still preliminary, protective role for statin medications.30PubMed Central. Pharmacologic treatment and SUDEP risk: A nationwide, population-based, case-control study This is one more reason why the adherence discussion above is not academic: every missed dose is a roll of the dice.
When and How to Stop Treatment
If you have been seizure-free for a sustained period, the question of whether to taper off medication eventually comes up. The general guideline is to consider tapering after two to five seizure-free years in adults and one to two years in children, but the decision is highly individual.31PubMed Central. Stopping Antiepileptic Drugs: When and Why?
The risk of relapse after stopping medication is real. An AAN practice advisory found that adults who tapered after two seizure-free years had roughly double the long-term recurrence rate compared to those who stayed on medication. In children, there does not appear to be a meaningful difference in outcomes between tapering at two years versus four years of seizure freedom.32PubMed. Antiseizure Medication Withdrawal in Seizure-Free Patients: Practice Advisory Update Summary Factors that raise the risk of relapse include a longer history of seizures before control was achieved, an abnormal EEG, multiple medications needed to gain control, and specifically a history of tonic-clonic seizures, which is associated with higher relapse rates compared to other seizure types.33Seizure. Stopping epilepsy treatment in seizure remission: Good or bad or both?
Even in people with favorable profiles, relapse rates of 20-25% are common, so the decision to taper always involves weighing the freedom from medication against the consequences of a recurrent seizure, which for an adult can mean losing driving privileges, workplace safety issues, or injury risk. Neurologists typically discuss these tradeoffs in detail before any taper begins.
Behavioral and Mood Medications Sometimes Used Alongside
Depression and anxiety are more common in people with epilepsy than in the general population, and undertreated mood disorders can worsen seizure control. Conversely, some anti-seizure medications can cause or worsen mood symptoms, as noted earlier with levetiracetam and perampanel. The treatment of mood disorders in epilepsy requires care because certain antidepressants can lower the seizure threshold at high doses, though at typical doses most modern antidepressants are considered safe. Selective serotonin reuptake inhibitors are generally preferred. The point is that treating seizures in isolation, without addressing co-existing mood or behavioral health, can leave people far from feeling well, even if the EEG looks clean. Integrated management that considers both brain health and mental health tends to produce better real-world outcomes than treating each problem in its own silo.